Menu Leading global technology-enabled scientific communications company Envision Pharma Group (“Envision” or the “Company”) has appointed Manish Goel as its new Global Head of Envision Technology Solutions (ETS) to drive the development of innovative technologies for the life sciences sector. Manish Goel brings over 15 years of leadership experience across the technology and healthcare sphere, and joins Envision from IQVIA where he served as the VP of Technology Solutions to lead the development of its customer engagement portfolio of technologies. At Envision, he will focus on the continuing transformation of iEnvision – the global medical affairs platform, solidifying its position as the leading Software as a Service (SaaS) platform and driving the development of innovative and differentiating capabilities for the medical affairs organization. Goel said, “With COVID-19 accelerating the pace of change in the medical affairs landscape, and the critical, enabling role iEnvision can play here for life science companies, this is an exciting time to join Envision as it embarks on its next phase of strategic growth.” He added, “I look forward to building on the strength of iEnvision’s existing solutions and customer relationships to deliver market-leading capabilities, that further extend our market position within the medical affairs function.” David Thompson, CEO, Envision, said, “With his technology pedigree, healthcare experience, and impressive track record, we are delighted to have Manish join Envision. As a proven leader, we look forward to embracing his tremendous expertise in writing the next chapter for iEnvision – establishing it as the gold standard for the medical affairs function as we identify, invest, and develop capabilities that enable us to spread beyond our medical affairs client base.” Dot grid. Related news View all news Our growing presence in Japan and the Asia-Pacific region News/events Our growing presence in Japan and the Asia-Pacific region August 30, 2017 Envision Pharma Group wins “Best Original Research” prize at ISMPP for the second year running News/events Envision Pharma Group wins “Best Original Research” prize at ISMPP for the second year running August 26, 2017 Envision Pharma Group announces the availability of Scopus citation counts in Datavision News/events Envision Pharma Group announces the availability of Scopus citation counts in Datavision April 24, 2017 Envision announces Altmetric attention data now available in Library™ scientific content management software News/events Envision announces Altmetric attention data now available in Library™ scientific content management software April 24, 2017 Envision Pharma Group launches Medinfo™ – a new purpose-built software solution for medical information News/events Envision Pharma Group launches Medinfo™ – a new purpose-built software solution for medical information March 20, 2017 iEnvision Contact us ISO/IEC 27001 Certification Twitter LinkedIn © 2001-2020 Envision Pharma Group. All rights reserved. Terms of use Privacy notice Cookies notice Privacy shield policy Modern slavery statement We use cookies on our website. By continuing to use this website, you consent to our use of cookies in accordance with our cookie policy. To learn more about cookies, how we use them, and how you can change your settings, please view our Cookies Notice Accept